ClinicalTrials.Veeva

Menu

Effects of Oxytocin and Vasopressin on Moral Decision Making

U

University of Electronic Science and Technology of China

Status

Completed

Conditions

Healthy

Treatments

Drug: Oxytocin
Drug: Placebo
Drug: Vasopressin

Study type

Interventional

Funder types

Other

Identifiers

NCT04890470
UESTC-neuSCAN-78

Details and patient eligibility

About

To determine whether the neuropeptide oxytocin (OXT) and vassopressin (AVP) influence moral decision making

Full description

In a double-blind, between- subject placebo (PLC) controlled design, subjects will first complete a series of questionnaires in terms of mood, clinical symptoms, and traits. After that their moral judgment and emotion towards both verbal descriptions of moral dilemma scenarios and pictures of specific interpersonal ones will be assessed and the effect of intranasal OXT and AVP between both male and female healthy subjects will be investigated.

Enrollment

180 patients

Sex

All

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy subjects without past or current psychiatric or neurological disorders

Exclusion criteria

  • pregnancy

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

180 participants in 3 patient groups, including a placebo group

oxytocin group
Experimental group
Description:
subjects with oxytocin treatment
Treatment:
Drug: Oxytocin
vasopressin group
Experimental group
Description:
subjects with vasopressin treatment
Treatment:
Drug: Vasopressin
placebo group
Placebo Comparator group
Description:
subjects with placebo treatment
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Keith M. Kendrick, Dr.; Benjamin Becker, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems